1. Home
  2. QNRX vs CPHI Comparison

QNRX vs CPHI Comparison

Compare QNRX & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNRX
  • CPHI
  • Stock Information
  • Founded
  • QNRX 2018
  • CPHI N/A
  • Country
  • QNRX United States
  • CPHI China
  • Employees
  • QNRX N/A
  • CPHI N/A
  • Industry
  • QNRX Medical/Dental Instruments
  • CPHI Biotechnology: Pharmaceutical Preparations
  • Sector
  • QNRX Health Care
  • CPHI Health Care
  • Exchange
  • QNRX Nasdaq
  • CPHI Nasdaq
  • Market Cap
  • QNRX 4.8M
  • CPHI 4.7M
  • IPO Year
  • QNRX N/A
  • CPHI N/A
  • Fundamental
  • Price
  • QNRX $7.90
  • CPHI $1.93
  • Analyst Decision
  • QNRX
  • CPHI
  • Analyst Count
  • QNRX 0
  • CPHI 0
  • Target Price
  • QNRX N/A
  • CPHI N/A
  • AVG Volume (30 Days)
  • QNRX 130.9K
  • CPHI 26.1K
  • Earning Date
  • QNRX 11-06-2025
  • CPHI 11-12-2025
  • Dividend Yield
  • QNRX N/A
  • CPHI N/A
  • EPS Growth
  • QNRX N/A
  • CPHI N/A
  • EPS
  • QNRX N/A
  • CPHI N/A
  • Revenue
  • QNRX N/A
  • CPHI $4,396,201.00
  • Revenue This Year
  • QNRX N/A
  • CPHI N/A
  • Revenue Next Year
  • QNRX N/A
  • CPHI N/A
  • P/E Ratio
  • QNRX N/A
  • CPHI N/A
  • Revenue Growth
  • QNRX N/A
  • CPHI N/A
  • 52 Week Low
  • QNRX $5.01
  • CPHI $1.20
  • 52 Week High
  • QNRX $54.95
  • CPHI $3.35
  • Technical
  • Relative Strength Index (RSI)
  • QNRX 57.03
  • CPHI 60.72
  • Support Level
  • QNRX $7.19
  • CPHI $1.85
  • Resistance Level
  • QNRX $7.92
  • CPHI $1.97
  • Average True Range (ATR)
  • QNRX 0.44
  • CPHI 0.11
  • MACD
  • QNRX 0.04
  • CPHI -0.01
  • Stochastic Oscillator
  • QNRX 82.59
  • CPHI 78.00

About QNRX Quoin Pharmaceuticals Ltd.

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

About CPHI China Pharma Holdings Inc.

China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.

Share on Social Networks: